Omnicare Makes Donation to the Neurodegeneration Consortium to Advance the Study and Treatment of Alzheimer's

CINCINNATI, May 23, 2014 - Omnicare, Inc. (NYSE: OCR) today announced a $50,000 donation to the Neurodegeneration Consortium (NDC), a collaboration of The University of Texas MD Anderson Cancer Center, Baylor College of Medicine and the Massachusetts Institute of Technology. The NDC is a transformative initiative to advance the study and treatment of Alzheimer's and other neurodegenerative diseases.

"Our organization plays a critical role in improving the quality of care for those afflicted with neurodegenerative diseases," said Nitin Sahney, Omnicare's President and Chief Operating Officer. "We are pleased to have the opportunity to partner with this initiative whose work is parallel to our services and core values, and to contribute to the community in a meaningful way."

The NDC's mission is to identify key molecular targets that cause Alzheimer's and other neurodegerative diseases and to rapidly translate these discoveries into treatments. Recent research has revealed common molecular themes in neurodegeneration, cancer and other age-associated diseases.

"We are deeply grateful to Omnicare for supporting the NDC's efforts to understand and overcome one of the greatest challenges facing humanity in this century," said Ron DePinho, M.D., president of MD Anderson. "Our aim is to find out how and why neurodegenerative diseases develop and to find the key steps to prevent or slow disease progression, while addressing quality of life issues and the financial challenges of living with Alzheimer's disease, Parkinson's disease and chemotherapy induced neuropathy. Philanthropy is the driving force behind this initiative, and Omnicare's generous gift of $50,000 is a much-needed boost to the NDC and its unique approach."

About Omnicare

Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across the United States.  As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care institutions, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit of its long-term care customers.  Omnicare also provides key commercialization services for the bio-pharmaceutical industry through its Specialty Care Group.  For more information, visit www.omnicare.com.

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute. For 10 of the past 12 years, including 2013, MD Anderson has ranked No. 1 in cancer care in "Best Hospitals," a survey published annually in U.S. News & World Report. MD Anderson receives a cancer center support grant from the National Cancer Institute of the National Institutes of Health (P30 CA016672).

# # #

Contacts:
Omnicare
Patrick C. Lee
(513) 719-1507
patrick.lee@omnicare.com

MD Anderson
Sarah Watson
(713) 745-6109
swatson@mdanderson.org